GrayBug LLC, a startup ophthalmic drug company spun out of Johns Hopkins University’s Wilmer Eye Institute, has hired its first full-time CEO and raised $1.5 million in new venture capital funding.
Michael O’Rourke, a veteran pharmaceutical industry executive and consultant, joined Baltimore-based GrayBug on Oct. 15. He comes to the company as it closed $1.5 million in funding from investors including the Maryland Venture Fund, the Abell Foundation and Brown Advisory, the Baltimore asset management firm.
{iframe}http://www.bizjournals.com/baltimore/news/2013/11/01/graybug-taps-ceo-15m-in-venture-money.html?ana=e_du_pub&s=article_du&ed=2013-11-01{/iframe}